Print
Email
Print Edition StoriesWednesday, June 3, 2009
Gene Network Sciences, UConn work on computer-modeled cancer treatments
By Mass High Tech staff
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban
Gene Network Sciences Inc. is working with the University of Connecticut Health Center’s Carole and Ray Neag Comprehensive Cancer Center to target ideal personalized medical treatments using computer models. The models generated by GNS combine genetic, genomic and clinical data.
The collaboration will be conducted first with patients diagnosed with ovarian cancer, with the goal of applying the computer models to other cancers. No financial terms of the collaboration were disclosed.
Two alumni originally started the collaboration between GNS and the Neag Comprehensive Cancer Center -- Tom Nayarapally and Carolyn Runowicz, director of the Center. The two are writing a scientific article, along with colleagues Molly Brewer and Iya Khalil, about the topic of supercomputing capabilities and ovarian cancer treatments.
GNS uses its technology in pharmaceutical and clinical settings to turn combinations of genetic, genomic and clinical measurements into disease progression and drug response models.
Founded in Ithaca, N.Y., in 2000, GNS opened an office in Cambridge in 2005. Despite the connection with UConn, GNS has close ties to Cornell University in Ithaca, where company CEO Colin Hill earned a master’s degree in physics.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
